225 related articles for article (PubMed ID: 32799885)
1. Particulate matters increase epithelial-mesenchymal transition and lung fibrosis through the ETS-1/NF-κB-dependent pathway in lung epithelial cells.
Chen YC; Chuang TY; Liu CW; Liu CW; Lee TL; Lai TC; Chen YL
Part Fibre Toxicol; 2020 Aug; 17(1):41. PubMed ID: 32799885
[TBL] [Abstract][Full Text] [Related]
2. PM
Liu CW; Lee TL; Chen YC; Liang CJ; Wang SH; Lue JH; Tsai JS; Lee SW; Chen SH; Yang YF; Chuang TY; Chen YL
Part Fibre Toxicol; 2018 Jan; 15(1):4. PubMed ID: 29329563
[TBL] [Abstract][Full Text] [Related]
3. [Chrysin inhibited epithelial-mesenchymal transition of type Ⅱ alveolar epithelial cell by regulating NF-κB/Twist 1 signaling pathway].
Lu LM; Fu Y; Li QY; He XW; Tang J; Li XW
Zhongguo Zhong Yao Za Zhi; 2021 Jan; 46(1):146-154. PubMed ID: 33645064
[TBL] [Abstract][Full Text] [Related]
4. YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells.
Zhang C; Zhu X; Hua Y; Zhao Q; Wang K; Zhen L; Wang G; Lü J; Luo A; Cho WC; Lin X; Yu Z
Respir Res; 2019 Nov; 20(1):249. PubMed ID: 31703732
[TBL] [Abstract][Full Text] [Related]
5. Osthole inhibited TGF β-induced epithelial-mesenchymal transition (EMT) by suppressing NF-κB mediated Snail activation in lung cancer A549 cells.
Feng H; Lu JJ; Wang Y; Pei L; Chen X
Cell Adh Migr; 2017 Sep; 11(5-6):464-475. PubMed ID: 28146373
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effects of particulate matter and substrate stiffness on epithelial-to-mesenchymal transition.
Barker TH; Dysart MM; Brown AC; Douglas AM; Fiore VF; Russell AG;
Res Rep Health Eff Inst; 2014 Nov; (182):3-41. PubMed ID: 25669020
[TBL] [Abstract][Full Text] [Related]
7. DNA repair enzyme OGG1 promotes alveolar progenitor cell renewal and relieves PM2.5-induced lung injury and fibrosis.
Yang L; Liu G; Fu L; Zhong W; Li X; Pan Q
Ecotoxicol Environ Saf; 2020 Dec; 205():111283. PubMed ID: 32977282
[TBL] [Abstract][Full Text] [Related]
8. TGF-β promote epithelial-mesenchymal transition via NF-κB/NOX4/ROS signal pathway in lung cancer cells.
Ma M; Shi F; Zhai R; Wang H; Li K; Xu C; Yao W; Zhou F
Mol Biol Rep; 2021 Mar; 48(3):2365-2375. PubMed ID: 33792826
[TBL] [Abstract][Full Text] [Related]
9. Dasatinib Suppresses TGFβ-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Inhibits Pulmonary Fibrosis.
Kanemaru R; Takahashi F; Kato M; Mitsuishi Y; Tajima K; Ihara H; Hidayat M; Wirawan A; Koinuma Y; Hayakawa D; Yagishita S; Ko R; Sato T; Harada N; Kodama Y; Nurwidya F; Sasaki S; Niwa SI; Takahashi K
Lung; 2018 Oct; 196(5):531-541. PubMed ID: 29926178
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition.
Tian B; Li X; Kalita M; Widen SG; Yang J; Bhavnani SK; Dang B; Kudlicki A; Sinha M; Kong F; Wood TG; Luxon BA; Brasier AR
BMC Genomics; 2015 Jul; 16(1):529. PubMed ID: 26187636
[TBL] [Abstract][Full Text] [Related]
11. Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation.
Tomei P; Masola V; Granata S; Bellin G; Carratù P; Ficial M; Ventura VA; Onisto M; Resta O; Gambaro G; Chilosi M; Lupo A; Zaza G
J Nephrol; 2016 Dec; 29(6):881-891. PubMed ID: 27026415
[TBL] [Abstract][Full Text] [Related]
12. PM2.5 induces EMT and promotes CSC properties by activating Notch pathway in vivo and vitro.
Wang Y; Zhong Y; Hou T; Liao J; Zhang C; Sun C; Wang G
Ecotoxicol Environ Saf; 2019 Aug; 178():159-167. PubMed ID: 31002970
[TBL] [Abstract][Full Text] [Related]
13. NF-κB pathway affects silica nanoparticle-induced fibrosis via inhibited inflammatory response and epithelial-mesenchymal transition in 3D co-culture.
Yang X; Zhang J; Xiong M; Yang Y; Yang P; Li N; Shi F; Zhu Y; Guo K; Jin Y
Toxicol Lett; 2023 Jul; 383():141-151. PubMed ID: 37394155
[TBL] [Abstract][Full Text] [Related]
14. Paeoniflorin suppresses TGF-β mediated epithelial-mesenchymal transition in pulmonary fibrosis through a Smad-dependent pathway.
Ji Y; Dou YN; Zhao QW; Zhang JZ; Yang Y; Wang T; Xia YF; Dai Y; Wei ZF
Acta Pharmacol Sin; 2016 Jun; 37(6):794-804. PubMed ID: 27133302
[TBL] [Abstract][Full Text] [Related]
15. β-carboline alkaloids attenuate bleomycin induced pulmonary fibrosis in mice through inhibiting NF-kb/p65 phosphorylation and epithelial-mesenchymal transition.
Cui Y; Jiang L; Yu R; Shao Y; Mei L; Tao Y
J Ethnopharmacol; 2019 Oct; 243():112096. PubMed ID: 31323300
[TBL] [Abstract][Full Text] [Related]
16. BRD4 mediates NF-κB-dependent epithelial-mesenchymal transition and pulmonary fibrosis via transcriptional elongation.
Tian B; Zhao Y; Sun H; Zhang Y; Yang J; Brasier AR
Am J Physiol Lung Cell Mol Physiol; 2016 Dec; 311(6):L1183-L1201. PubMed ID: 27793799
[TBL] [Abstract][Full Text] [Related]
17. NF-κB Mediates Mesenchymal Transition, Remodeling, and Pulmonary Fibrosis in Response to Chronic Inflammation by Viral RNA Patterns.
Tian B; Patrikeev I; Ochoa L; Vargas G; Belanger KK; Litvinov J; Boldogh I; Ameredes BT; Motamedi M; Brasier AR
Am J Respir Cell Mol Biol; 2017 Apr; 56(4):506-520. PubMed ID: 27911568
[TBL] [Abstract][Full Text] [Related]
18. Placental Growth Factor Triggers Epithelial-to-Mesenchymal Transition-like Changes in Rat Type II Alveolar Epithelial Cells: Activation of Nuclear Factor κB Signalling Pathway.
Zhang L; Zhao S; Yuan L; Wu H; Jiang H; Luo G
Basic Clin Pharmacol Toxicol; 2016 Nov; 119(5):498-504. PubMed ID: 27154788
[TBL] [Abstract][Full Text] [Related]
19. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
[TBL] [Abstract][Full Text] [Related]
20. Plantamajoside inhibits lipopolysaccharide-induced epithelial-mesenchymal transition through suppressing the NF-κB/IL-6 signaling in esophageal squamous cell carcinoma cells.
Li X; Chen D; Li M; Gao X; Shi G; Zhao H
Biomed Pharmacother; 2018 Jun; 102():1045-1051. PubMed ID: 29710521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]